jungle4321
New member
that is actually where most of it happened--California---but the upside was if you are blind more people may buy your apples for 5 cents![]()
lol
that is actually where most of it happened--California---but the upside was if you are blind more people may buy your apples for 5 cents![]()
This is a proposed mechanism of action, which I appreciate. However, it's far from evidence. Do you have any references that these steps occur in humans? I don't think I've ever heard anyone report a reduction in thyroid levels after a cycle of clenbuterol. Unless there's some decent evidence that these steps occur in humans, or even direct evidence in animals that clenbuterol suppresses metabolism, I think it's very premature for you to be making statements of fact like "on the off days, your metabolism rebounds into a slower range" and that "you have a net lowering of your metabolism."
Your link doesn't work. Further, this quote is far from an authoratative excerpt. I found the whole text, and it looks like an article on tainted meat from a student in an animal science class. It has no references. The excerpt immediately preceding the one you posted should make you question the accuracy of the whole paper: "Athletes generally take a 20 mcg dose 3 times a day for 2 days then go off it for 2 days. They repeat this cycle for 6-8 weeks." If you have any actual evidence that clenbuterol causes a reduction in metabolic rate upon cessation, please post it.
You discount the theory but cannot discount that each of the mechanism is well-founded. As far as the statement being premature, in the absence of actual studies, it is reasonable to postulate that, based on established physiologic mechanisms, that there would be a decrease in metabolism. You cannot keep returning to the lack of human studies when you know well and good that the clen studies do not look at metabolism as that is not necessary to the narrow scope of the study (e.g. the one human study you trot out continually)
Yes, I will definitely argue that the "the studies that proved such were not on humans" and "with doses exponentially higher than that which would be used in humans." I've already posted research IN HUMANS, in which three months of very high doses of clen resulted in no significant change in collagen deposition. “
Your reliance on ONE flawed human study, of 7 human research subjects--(patients at end stage cardiac failure) is not well placed and downright misleading and scientifically invalid given the nature of the study and the many absolute conflicting studies. Aside from the size of the group, lack of control, lack of placebo, and the fact that the conclusion was that clen may induce cardiac hypertrophy and therefore helpful to left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy.
Moreover, your entire hypothesis is predicated on the fact that “ No significant change in myocyte size or collagen deposition was seen”---(1) what is significant; (2) the observations were not based on actual post mortem examinations of the cardiac muscle (as was done in all the other mammalian studies); and again, this was short term, not done in the manner in which clen is used illicitly, and the subjects were not comparable to illicit users, save for the fact that they were human (about the only similarity)
I've already addressed cardiomyocyte toxicity and necrosis here in this thread.
Also, I didn't see you respond to this: do you have any references for your claimn that there is a degredation in cardiac output, especially in humans or at doses relevant to human use?
again, there has not been any human studies--except the off-point and flawed one you cite. Can you actually suggest that collagen deposition in cardiac muscle cannot adversely impact the net output? See http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/NDARCFact_Drugs2/$file/CLENBUTEROL+NDARC+FACT+SHEET.pdf ( “Collagen is a tough connective tissue that can stiffen the heart muscle, actually reducing cardiac output and possibly producing cardiac arrhythmias. Also, clenbuterol rats suffered from noticeable cardiac-cell degeneration”)
[FONT="]Occam's Razor?
I don't think anyone thinks that clen is magic or completely safe. I think that's a fallacious straw man. Rather, I think clen has utility for mobilizing fat when there's a large caloric deficit. It's useful at low BF percentages when there's little fat left to mobilize. It also has utility as an anti-catabolic during dieting. Magic? No.
DNP, on the other hand, is about as close to magic as you can get. Can it cause cataracts? Yes. Of the estimated 500,000 people who took DNP in the 1930's, there were 164 case reports of cataracts, according to Horner's extensive 1941 review. They're rare, but are one of DNP's most serious risks. There appears to be a genetic factor causing suscpetibility. There's also reason to think that antioxidant supplemention might prevent their occurance (even though uncouplers reduce mitochondrial oxidative stress). That's because DNP induced cataracts are caused by a rare, second-order metabolite of DNP that is a cataractogenic semiquinone.
The main problem with DNP is that people don't know how to use it properly. Like clen, doses need to be carefully titrated and kept relatively low. Take too much, like most bodybuilders do, and you'll add undue risks and side effects.
I sound like a competitor trying to sell clen? I hope I sound more educated than that. I'm not selling anything, I'm just a bodybuilding enthusiast.
As for saving the children, I don't think anything should stand in the way of objective discussion about the facts, even if it means calling into question some of the dangers that are used for scare tactics. Hopefully we learned something from steroids and the disingenuous anti-steroid propaganda.
You discount the theory but cannot discount that each of the mechanism is well-founded. As far as the statement being premature, in the absence of actual studies, it is reasonable to postulate that, based on established physiologic mechanisms, that there would be a decrease in metabolism. You cannot keep returning to the lack of human studies when you know well and good that the clen studies do not look at metabolism as that is not necessary to the narrow scope of the study (e.g. the one human study you trot out continually)
Your reliance on ONE flawed human study, of 7 human research subjects--(patients at end stage cardiac failure) is not well placed and downright misleading and scientifically invalid given the nature of the study and the many absolute conflicting studies. Aside from the size of the group, lack of control, lack of placebo, and the fact that the conclusion was that clen may induce cardiac hypertrophy and therefore helpful to left ventricular assist devices for the treatment of end-stage heart failure to reverse or prevent the adverse effects of unloading-induced myocardial atrophy.
Moreover, your entire hypothesis is predicated on the fact that “ No significant change in myocyte size or collagen deposition was seen”---(1) what is significant; (2) the observations were not based on actual post mortem examinations of the cardiac muscle (as was done in all the other mammalian studies); and again, this was short term, not done in the manner in which clen is used illicitly, and the subjects were not comparable to illicit users, save for the fact that they were human (about the only similarity)
again, there has not been any human studies--except the off-point and flawed one you cite. Can you actually suggest that collagen deposition in cardiac muscle cannot adversely impact the net output? See http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/NDARCFact_Drugs2/$file/Clenbuterol+NDARC+FACT+SHEET.pdf ( “Collagen is a tough connective tissue that can stiffen the heart muscle, actually reducing cardiac output and possibly producing cardiac arrhythmias. Also, Clenbuterol rats suffered from noticeable cardiac-cell degeneration”)
To address your point, your imply that because is that clen has not been proven to be unsafe for human use and in spite of numerous studies in non human mammals, it is safe. You may take issue with such an inference but it is none-the-less a valid one.
As for DNP, we both know it is being studied now--at least its mechanism is, for a potential weight loss drug. The problem is that while you note the incidence of vision-related adverse occurrence may or may not be statistically significant and may result from some genetic predisposition, and as you note the doses taken then and illicitly now are not comparable, the ration of a therapeutic dose and potentially deadly dose is so small as to warrant the gravest of warning against its use--not to mention the risk of the actual dose from an illicit source is palpable.
Finally, I stand by my supposition that if clen was indeed thought to be effective w/o reasonable risk why is it not marketed as such? The simplest answer is most-likely the correct one: the risk/benefit is not economically nor ethically acceptable.
This page contains mature content. By continuing, you confirm you are over 18 and agree to our TOS and User Agreement.